NCT00902785终止不适用
A Two-Year Exploratory, Observational, Non-Interventional Multicenter Study To Identify Early Markers Of Choroidal Neovascularization In Fellow Eyes Of Patients With Neovascular AMD In One Eye
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- Pfizer
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Identify the sequence of change in the chorioretinal interface during the development of CNV and the progression from dry to neovascular AMD.
研究概览
简要总结
Identify early markers of choroidal neovascularization (CNV) in the fellow eye of a patient with CNV in the other eye due to age-related macular degeneration with the expectation of being able to identify patients in need of intervention.
详细描述
CNV in one eye and dry AMD in the other
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Sub-, extra- or juxta-foveal choroidal neovascularization (CNV) or macular scar due to AMD in the non-study eye.
- •No CNV or geographic atrophy in the study eye.
- •Best corrected visual acuity in the study eye of greater than 20/40 or better than 70 ETDRS letters.
- •Sufficiently clear ocular media and adequate pupillary dilatation to permit good quality fundus imaging of the study eye.
- •Subjects of either sex, aged 50 years.
- •Evidence of a signed and dated informed consent document indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the trial.
- •Willing and able to comply with scheduled visits, laboratory tests, and other trial procedures.
排除标准
- •Subjects presenting with any of the following will not be included in the study:
- •Evidence of manifest CNV by FA, color photography or ICG angiography in the study eye.
- •Any prior treatment for CNV to the study eye (excluding vitamins and AREDS formula).
- •Significant media opacities, including cataract, which might interfere with visual acuity assessments, or fundus imaging in the study eye. Subjects should not be entered if there is likelihood that they will require cataract surgery within the following 2 years.
- •Presence of other causes of choroidal neovascularization in the fellow eye, including pathologic myopia (spherical equivalent of -8 diopters or more negative, or axial length of 25 mm or more), the ocular histoplasmosis syndrome, angioid streaks, choroidal rupture, and multifocal choroiditis.
- •Any progressive eye disease other than AMD (eg, glaucoma, diabetic retinopathy) in the study eye.
- •Presence of subretinal hemorrhage, serous or hemorrhagic pigment epithelial detachments, subretinal fibrosis or pigment epithelial tears or rips in the study eye.
- •Any medical condition that would interfere with the patient's ability to complete the trial.
- •Concurrent enrollment in any other observational or interventional clinical study.
- •Any treatment with an ocular or systemic investigational agent in the past 60 days for any medical condition.
- •Known serious allergies to the dye used in fluorescein angiography or ICG.
结局指标
主要结局
Identify the sequence of change in the chorioretinal interface during the development of CNV and the progression from dry to neovascular AMD.
时间窗: 2 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Population-based Study of Macular Choroidal Neovascularization in a Chinese PopulationGeographic AtrophyWet Macular DegenerationRetinal DrusenNCT01666821Shanghai University of Traditional Chinese Medicine59
尚未招募
不适用
Study on the Biomarkers of Anti-VEGF Treatment for Choroidal NeovascularizationChoroidal NeovascularizationNCT06243406Beijing Hospital80
已完成
3 期
Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular DegenerationNeovascular Age-Related Macular DegenerationNCT04264819Novartis Pharmaceuticals295
已完成
2 期
Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA).Inflammatory Choroidal NeovascularizationNCT02556229Hospices Civils de Lyon20
Unknown
3 期
Manta Study: Avastin Versus Lucentis in Age Related Macular DegenerationAge Related Macular DegenerationNCT00710229The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery320